Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y, Okuyama M, Juji T
Division of Endocrinology and Metabolism, Jichi Medical School, Tochigi-Ken, Japan.
Diabetes. 1990 Feb;39(2):266-9. doi: 10.2337/diab.39.2.266.
The HLA-DQ beta-chain (DQB1) genes of 72 Japanese patients with insulin-dependent diabetes mellitus (IDDM) and 85 control subjects were studied with polymerase chain-reaction (PCR) amplification and allele-specific oligonucleotide hybridization. DQW4 (DQBBlank) and DQw9 (DQB3.3) were increased in IDDM patients compared with the control subjects, and DQB1.2, DQB1.9, and DQw7 (DQB3.1) were decreased. Thirty-five (48.6%) IDDM patients had both alleles carrying an aspartic acid at position 57 of the DQ beta-chain (Asp 57), 35 (48.6%) were Asp 57/non-Asp 57 heterozygous, and 2 (2.8%) had non-Asp 57 alleles only. Of 85 control subjects, the respective values for these three genotypes were 49 (57.6%), 29 (34.1%), and 7 (8.2%), respectively. The high frequency of Asp 57 alleles in both IDDM and control subjects contrasts with data for Whites. Therefore, the Asp 57 hypothesis that the presence of an aspartic acid at position 57 of DQ beta-chain provides protection against developing IDDM is not tenable for Japanese IDDM patients. The DRB1 gene, particularly position 57 of the DR beta-chain, may contribute to IDDM susceptibility in Japanese.
采用聚合酶链反应(PCR)扩增和等位基因特异性寡核苷酸杂交技术,对72例日本胰岛素依赖型糖尿病(IDDM)患者和85例对照者的HLA - DQβ链(DQB1)基因进行了研究。与对照者相比,IDDM患者中DQW4(DQBBlank)和DQw9(DQB3.3)增加,而DQB1.2、DQB1.9和DQw7(DQB3.1)减少。35例(48.6%)IDDM患者的两个等位基因在DQβ链第57位均携带天冬氨酸(Asp 57),35例(48.6%)为Asp 57/非Asp 57杂合子,2例(2.8%)仅具有非Asp 57等位基因。在85例对照者中,这三种基因型的相应比例分别为49例(57.6%)、29例(34.1%)和7例(8.2%)。IDDM患者和对照者中Asp 57等位基因的高频率与白人的数据形成对比。因此,关于DQβ链第57位存在天冬氨酸可提供对IDDM发病保护作用的Asp 57假说,对于日本IDDM患者是不成立的。DRB1基因,特别是DRβ链的第57位,可能在日本人IDDM易感性中起作用。